166 related articles for article (PubMed ID: 16951200)
21. The role of dUTPase and uracil-DNA repair in cancer chemotherapy.
Ladner RD
Curr Protein Pept Sci; 2001 Dec; 2(4):361-70. PubMed ID: 12374095
[TBL] [Abstract][Full Text] [Related]
22. Ung1p-mediated uracil-base excision repair in mitochondria is responsible for the petite formation in thymidylate deficient yeast.
Chien CY; Chou CK; Su JY
FEBS Lett; 2009 May; 583(9):1499-504. PubMed ID: 19362086
[TBL] [Abstract][Full Text] [Related]
23. Expression of uracil DNA glycosylase (UDG) does not affect cellular sensitivity to thymidylate synthase (TS) inhibition.
Welsh SJ; Hobbs S; Aherne GW
Eur J Cancer; 2003 Feb; 39(3):378-87. PubMed ID: 12565992
[TBL] [Abstract][Full Text] [Related]
24. Uracil in DNA--general mutagen, but normal intermediate in acquired immunity.
Kavli B; Otterlei M; Slupphaug G; Krokan HE
DNA Repair (Amst); 2007 Apr; 6(4):505-16. PubMed ID: 17116429
[TBL] [Abstract][Full Text] [Related]
25. Proteolytic degradation of the nuclear isoform of uracil-DNA glycosylase occurs during the S phase of the cell cycle.
Fischer JA; Muller-Weeks S; Caradonna S
DNA Repair (Amst); 2004 May; 3(5):505-13. PubMed ID: 15084312
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of Human Uracil DNA Glycosylase Sensitizes a Large Fraction of Colorectal Cancer Cells to 5-Fluorodeoxyuridine and Raltitrexed but Not Fluorouracil.
Christenson ES; Gizzi A; Cui J; Egleston M; Seamon KJ; DePasquale M; Orris B; Park BH; Stivers JT
Mol Pharmacol; 2021 Jun; 99(6):412-425. PubMed ID: 33795350
[TBL] [Abstract][Full Text] [Related]
27. New mechanism of action of the cancer chemotherapeutic agent 5-fluorouracil in human cells.
Wurzer JC; Tallarida RJ; Sirover MA
J Pharmacol Exp Ther; 1994 Apr; 269(1):39-43. PubMed ID: 8169845
[TBL] [Abstract][Full Text] [Related]
28. Poly(ADP-Ribose) polymerase inhibition synergizes with 5-fluorodeoxyuridine but not 5-fluorouracil in ovarian cancer cells.
Huehls AM; Wagner JM; Huntoon CJ; Geng L; Erlichman C; Patel AG; Kaufmann SH; Karnitz LM
Cancer Res; 2011 Jul; 71(14):4944-54. PubMed ID: 21613406
[TBL] [Abstract][Full Text] [Related]
29. Analysis of nuclear uracil-DNA glycosylase (nUDG) turnover during the cell cycle.
Fischer JA; Caradonna S
Methods Mol Biol; 2011; 761():137-49. PubMed ID: 21755446
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of transcription factor AP-2 stimulates the PA promoter of the human uracil-DNA glycosylase (UNG) gene through a mechanism involving derepression.
Aas PA; Peña-Diaz J; Liabakk NB; Krokan HE; Skorpen F
DNA Repair (Amst); 2009 Jul; 8(7):822-33. PubMed ID: 19411194
[TBL] [Abstract][Full Text] [Related]
31. Antifolate-induced misincorporation of deoxyuridine monophosphate into DNA by cells from patients with the fragile X syndrome.
Wang JC; Beardsley GP; Erbe RW
Am J Med Genet; 1985 Aug; 21(4):691-6. PubMed ID: 2992271
[TBL] [Abstract][Full Text] [Related]
32. Insights from xanthine and uracil DNA glycosylase activities of bacterial and human SMUG1: switching SMUG1 to UDG.
Mi R; Dong L; Kaulgud T; Hackett KW; Dominy BN; Cao W
J Mol Biol; 2009 Jan; 385(3):761-78. PubMed ID: 18835277
[TBL] [Abstract][Full Text] [Related]
33. Real-time monitoring of uracil removal by uracil-DNA glycosylase using fluorescent resonance energy transfer probes.
Liu B; Yang X; Wang K; Tan W; Li H; Tang H
Anal Biochem; 2007 Jul; 366(2):237-43. PubMed ID: 17553452
[TBL] [Abstract][Full Text] [Related]
34. Cloning and characterization of uracil-DNA glycosylase and the biological consequences of the loss of its function in the nematode Caenorhabditis elegans.
Nakamura N; Morinaga H; Kikuchi M; Yonekura S; Ishii N; Yamamoto K; Yonei S; Zhang QM
Mutagenesis; 2008 Sep; 23(5):407-13. PubMed ID: 18524757
[TBL] [Abstract][Full Text] [Related]
35. Deficient uracil base excision repair leads to persistent dUMP in HIV proviruses during infection of monocytes and macrophages.
Meshesha M; Esadze A; Cui J; Churgulia N; Sahu SK; Stivers JT
PLoS One; 2020; 15(7):e0235012. PubMed ID: 32663205
[TBL] [Abstract][Full Text] [Related]
36. The rate of base excision repair of uracil is controlled by the initiating glycosylase.
Visnes T; Akbari M; Hagen L; Slupphaug G; Krokan HE
DNA Repair (Amst); 2008 Nov; 7(11):1869-81. PubMed ID: 18721906
[TBL] [Abstract][Full Text] [Related]
37. Checkpoint signaling, base excision repair, and PARP promote survival of colon cancer cells treated with 5-fluorodeoxyuridine but not 5-fluorouracil.
Geng L; Huehls AM; Wagner JM; Huntoon CJ; Karnitz LM
PLoS One; 2011; 6(12):e28862. PubMed ID: 22194930
[TBL] [Abstract][Full Text] [Related]
38. 5-chloro-2'-deoxyuridine cytotoxicity results from base excision repair of uracil subsequent to thymidylate synthase inhibition.
Brandon ML; Mi L; Chaung W; Teebor G; Boorstein RJ
Mutat Res; 2000 Mar; 459(2):161-9. PubMed ID: 10725666
[TBL] [Abstract][Full Text] [Related]
39. Genomic uracil and human disease.
Hagen L; Peña-Diaz J; Kavli B; Otterlei M; Slupphaug G; Krokan HE
Exp Cell Res; 2006 Aug; 312(14):2666-72. PubMed ID: 16860315
[TBL] [Abstract][Full Text] [Related]
40. The human base excision repair enzyme SMUG1 directly interacts with DKC1 and contributes to RNA quality control.
Jobert L; Skjeldam HK; Dalhus B; Galashevskaya A; Vågbø CB; Bjørås M; Nilsen H
Mol Cell; 2013 Jan; 49(2):339-45. PubMed ID: 23246433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
